Scientists have been able to track how a multi-drug resistant organism is able to evolve and spread widely among cystic fibrosis patients – showing that it can evolve rapidly within an individual during chronic infection.
Experiencing bullying and forms of aggression in late adolescence and early adulthood is linked to a marked increase in the likelihood of having daydreams or fantasies about hurting or killing people, according to a new study.
A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project.
Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.
Twelve University of Cambridge researchers have won advanced grants from the European Research Council (ERC), Europe’s premier research funding body. Their work is set to provide new insights into many subjects, such as how to deal with vast scales of data in a statistically robust way, the development of energy-efficient materials for a zero-carbon world, and the development of new treatments for degenerative disease and cancer. Cambridge has the most grant winners of any UK institution, and the second-most winners overall.
A new study in laboratory rats has discovered a direct link between low oxygen in the womb and impaired memory function in the adult offspring. It also finds that anti-oxidant supplements during pregnancy may protect against this.